🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
A Global Milestone for Wellness: Chanelle McCoy Health Secures Historic Dual SFDA and European Novel Food Regulatory Approvals The Digital and Regulatory Frontier: Top 10 Technical and GMP Trends Shaping Pharma in 2026 Funding the Future: Inside the €75k Women TechEU and £10M Createch Grants for Startups and SMEs FDA Fires Warning Shot at Sanofi's Irish Plant Over Data Cover-Up and Altuviiio Quality Failings Top Universities in Ireland: Discover the Country's Leading Higher Education Institutions The Irish Startup Ecosystem: A Comprehensive Funding and Development Guide for Entrepreneurs Addiction Counsellors of Ireland Launch Strategic Plan 2026–2029 to Prepare for CORU Regulation Ireland Funds €426,000 Behavioral App for Alcohol Reduction Amid Record Treatment Demand A Global Milestone for Wellness: Chanelle McCoy Health Secures Historic Dual SFDA and European Novel Food Regulatory Approvals The Digital and Regulatory Frontier: Top 10 Technical and GMP Trends Shaping Pharma in 2026 Funding the Future: Inside the €75k Women TechEU and £10M Createch Grants for Startups and SMEs FDA Fires Warning Shot at Sanofi's Irish Plant Over Data Cover-Up and Altuviiio Quality Failings Top Universities in Ireland: Discover the Country's Leading Higher Education Institutions The Irish Startup Ecosystem: A Comprehensive Funding and Development Guide for Entrepreneurs Addiction Counsellors of Ireland Launch Strategic Plan 2026–2029 to Prepare for CORU Regulation Ireland Funds €426,000 Behavioral App for Alcohol Reduction Amid Record Treatment Demand
Markets · 15 min delay
NBI4,187.6▲ +1.14%
PFE28.42▼ -0.38%
AZN74.18▲ +0.81%
NVO103.55▲ +2.07%
ROG261.40▼ -0.55%
ABBV174.92▲ +0.29%
EUR/USD1.0842▼ -0.12%
ISEQ9,241.3▲ +0.62%
NBI4,187.6▲ +1.14%
PFE28.42▼ -0.38%
AZN74.18▲ +0.81%
NVO103.55▲ +2.07%
ROG261.40▼ -0.55%
ABBV174.92▲ +0.29%
EUR/USD1.0842▼ -0.12%
Updated 04 Jul 2026 · HPRA open data

Pomalidomide - Medicines in Ireland

36 authorised products containing Pomalidomide, from the HPRA register.

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0–9
Showing 36 authorised medicines
MedicineActive substanceLicence holderStatus
Imnovid 1 mg hard capsules
EU/1/13/850/001
Pomalidomide Bristol-Myers Squibb Pharma EEIG
Imnovid 2 mg hard capsules
EU/1/13/850/002
Pomalidomide Bristol-Myers Squibb Pharma EEIG
Imnovid 3 mg hard capsules
EU/1/13/850/003
Pomalidomide Bristol-Myers Squibb Pharma EEIG
Imnovid 4 mg hard capsules
EU/1/13/850/004
Pomalidomide Bristol-Myers Squibb Pharma EEIG
Pomalidomide Accord 1 mg hard capsules
EU/1/24/1831/001-006
Pomalidomide Accord Healthcare S.L.U.
Pomalidomide Accord 2 mg hard capsules
EU/1/24/1831/007-012
Pomalidomide Accord Healthcare S.L.U.
Pomalidomide Accord 3 mg hard capsules
EU/1/24/1831/013-018
Pomalidomide Accord Healthcare S.L.U.
Pomalidomide Accord 4 mg hard capsules
EU/1/24/1831/019-024
Pomalidomide Accord Healthcare S.L.U.
Pomalidomide Clonmel 1 mg hard capsules
PA0126/378/001
Pomalidomide Clonmel Healthcare Ltd Marketed
Pomalidomide Clonmel 2 mg hard capsules
PA0126/378/002
Pomalidomide Clonmel Healthcare Ltd Marketed
Pomalidomide Clonmel 3 mg hard capsules
PA0126/378/003
Pomalidomide Clonmel Healthcare Ltd Marketed
Pomalidomide Clonmel 4 mg hard capsules
PA0126/378/004
Pomalidomide Clonmel Healthcare Ltd Marketed
Pomalidomide Grindeks 1 mg hard capsule
PA22992/022/001
Pomalidomide AS Grindeks Not marketed
Pomalidomide Grindeks 2 mg hard capsule
PA22992/022/002
Pomalidomide AS Grindeks Not marketed
Pomalidomide Grindeks 3 mg hard capsule
PA22992/022/003
Pomalidomide AS Grindeks Not marketed
Pomalidomide Grindeks 4 mg hard capsule
PA22992/022/004
Pomalidomide AS Grindeks Not marketed
Pomalidomide Krka 1 mg hard capsules
EU/1/24/1832/001-002
Pomalidomide Krka, d.d., Novo mesto
Pomalidomide Krka 2 mg hard capsules
EU/1/24/1832/003-004
Pomalidomide Krka, d.d., Novo mesto
Pomalidomide Krka 3 mg hard capsules
EU/1/24/1832/005-006
Pomalidomide Krka, d.d., Novo mesto
Pomalidomide Krka 4 mg hard capsules
EU/1/24/1832/007-008
Pomalidomide Krka, d.d., Novo mesto
Pomalidomide Rowex 1 mg hard capsules
PA0711/338/001
Pomalidomide Rowex Limited, Not marketed
Pomalidomide Rowex 2 mg hard capsules
PA0711/338/002
Pomalidomide Rowex Limited, Marketed
Pomalidomide Rowex 3 mg hard capsules
PA0711/338/003
Pomalidomide Rowex Limited, Marketed
Pomalidomide Rowex 4 mg hard capsules
PA0711/338/004
Pomalidomide Rowex Limited, Marketed
Pomalidomide Teva 1 mg Capsule, hard
EU/1/24/1868/001-012
Pomalidomide TEVA GmbH
Pomalidomide Teva 2 mg Capsule, hard
EU/1/24/1868/013-024
Pomalidomide TEVA GmbH
Pomalidomide Teva 3 mg Capsule, hard
EU/1/24/1868/025-036
Pomalidomide TEVA GmbH
Pomalidomide Teva 4 mg Capsule, hard
EU/1/24/1868/037-048
Pomalidomide TEVA GmbH
Pomalidomide Viatris 1 mg hard capsules
EU/1/23/1785/001-004
Pomalidomide Viatris Limited
Pomalidomide Viatris 2 mg hard capsules
EU/1/23/1785/005-008
Pomalidomide Viatris Limited
Pomalidomide Viatris 3 mg hard capsules
EU/1/23/1785/009-012
Pomalidomide Viatris Limited
Pomalidomide Viatris 4 mg hard capsules
EU/1/23/1785/013-016
Pomalidomide Viatris Limited
Pomalidomide Zentiva 1 mg hard capsules
EU/1/24/1830/001-004
Pomalidomide Zentiva k.s.
Pomalidomide Zentiva 2 mg hard capsules
EU/1/24/1830/005-008
Pomalidomide Zentiva k.s.
Pomalidomide Zentiva 3 mg hard capsules
EU/1/24/1830/009-012
Pomalidomide Zentiva k.s.
Pomalidomide Zentiva 4 mg hard capsules
EU/1/24/1830/013-016
Pomalidomide Zentiva k.s.
Cite this database

Priya Life Science (2026). Irish Medicines Database. Available at: https://priyalifescience.com/medicines (Accessed: 5 July 2026).

Data: Health Products Regulatory Authority (HPRA) open dataset (“Authorised or Transfer Pending Products”), licensed CC BY 4.0, refreshed daily. Regulatory information only — not medical advice.